Your browser doesn't support javascript.
loading
Outcomes of endoscopic therapy in donation after cardiac death liver transplant biliary strictures.
Kohli, Divyanshoo R; Harrison, M E; Mujahed, Tala; Fukami, Norio; Faigel, Douglas O; Pannala, Rahul; Moss, Adyr; Aqel, Bashar A.
Afiliação
  • Kohli DR; Division of Gastroenterology and Hepatology, Mayo Clinic, AZ, United States; Division of Gastroenterology and Hepatology, Kansas City VA Medical Center, MO, United States. Electronic address: kohli015@gmail.com.
  • Harrison ME; Division of Gastroenterology and Hepatology, Mayo Clinic, AZ, United States.
  • Mujahed T; Mayo Clinic School of Medicine, Mayo Clinic, AZ, United States.
  • Fukami N; Division of Gastroenterology and Hepatology, Mayo Clinic, AZ, United States.
  • Faigel DO; Division of Gastroenterology and Hepatology, Mayo Clinic, AZ, United States.
  • Pannala R; Division of Gastroenterology and Hepatology, Mayo Clinic, AZ, United States.
  • Moss A; Department of Surgery, Mayo Clinic, AZ, United States.
  • Aqel BA; Division of Gastroenterology and Hepatology, Mayo Clinic, AZ, United States.
HPB (Oxford) ; 22(7): 979-986, 2020 07.
Article em En | MEDLINE | ID: mdl-31676256
ABSTRACT

BACKGROUND:

Biliary strictures after donation-after-cardiac-death (DCD) liver transplantation (LT) require multiple endoscopic retrograde cholangiopancreatographies (ERCP). The outcomes of endoscopic dilation and maximal stenting are not well-characterized in this high-risk population.

METHODS:

DCD LT recipients who underwent LT and ERCP from 2012-2018 were selected. Anastomotic and non-anastomotic strictures were treated with balloon dilation and maximal stenting. A successful stent-free trial was defined as absence of biochemical, clinical or imaging evidence of strictures on follow-up exceeding 6 months. Adverse events were defined as unplanned admission or inpatient evaluation within 7 days of ERCP.

RESULTS:

Forty-nine DCD LT recipients underwent ERCP and 34 patients were diagnosed with strictures (20 anastomotic). Stent-free trial was successful in 27 patients. Adverse events occurred after 20 ERCPs. Patients with anastomotic strictures required fewer stents (1.43 ± 1.37 vs 2.63 ± 1.66; P < 0.001), shorter procedure and fluoroscopy times (34.15 ± 20.9 vs 59.6 ± 30.7 minutes, P < 0.001; 5.99 ± 7.4 vs 14.73 ± 10.74 minutes, P < 0.001), fewer relapses (10% vs 57%, P = 0.003), shorter intervals between initial ERCP and stent-free success (136.9 ± 118.3 vs 399.56 ± 234.7; P = 0.003), and between LT and stent-free success (227.8 ± 171.9 vs 464.1 ± 224.6 days; P = 0.005) compared to non-anastomotic strictures.

CONCLUSION:

Endoscopic dilation and maximal stenting resolves biliary strictures in DCD LT recipients with sustained success and relatively few adverse events.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colestase / Transplante de Fígado Tipo de estudo: Etiology_studies / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colestase / Transplante de Fígado Tipo de estudo: Etiology_studies / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article